You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

~ Buy the FOLOTYN (pralatrexate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR FOLOTYN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Folotyn

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00052442 ↗	10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma	Completed	Memorial Sloan Kettering Cancer Center	Phase 1/Phase 2	2002-08-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 10-propargyl-10-deazaaminopterin in treating patients who have recurrent or refractory non-Hodgkin's lymphoma or Hodgkin's lymphoma.
NCT00052442 ↗	10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma	Completed	National Cancer Institute (NCI)	Phase 1/Phase 2	2002-08-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 10-propargyl-10-deazaaminopterin in treating patients who have recurrent or refractory non-Hodgkin's lymphoma or Hodgkin's lymphoma.
NCT00052442 ↗	10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma	Completed	Spectrum Pharmaceuticals, Inc	Phase 1/Phase 2	2002-08-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 10-propargyl-10-deazaaminopterin in treating patients who have recurrent or refractory non-Hodgkin's lymphoma or Hodgkin's lymphoma.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Folotyn

Condition Name

Chart
Table

Condition Name for Folotyn
Intervention	Trials
Peripheral T-cell Lymphoma	3
Anaplastic Large Cell Lymphoma	2
Non-small Cell Lung Cancer	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Folotyn
Intervention	Trials
Lymphoma	16
Lymphoma, T-Cell	11
Lymphoma, T-Cell, Peripheral	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Folotyn

Trials by Country

Map
Table

Trials by Country for Folotyn
Location	Trials
United States	84
France	7
Hungary	7
United Kingdom	7
India	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Folotyn
Location	Trials
New York	12
California	8
Texas	6
New Jersey	5
Illinois	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Folotyn

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Folotyn
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 2	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Folotyn
Clinical Trial Phase	Trials
Completed	15
Recruiting	4
Withdrawn	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Folotyn

Sponsor Name

Chart
Table

Sponsor Name for Folotyn
Sponsor	Trials
Spectrum Pharmaceuticals, Inc	14
Acrotech Biopharma LLC	8
National Cancer Institute (NCI)	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Folotyn
Sponsor	Trials
Industry	29
Other	16
NIH	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.